Sponsors (55)
Authorizes HHS research and state grants to expand early detection, intervention, outreach, and research on uterine fibroids and related intrauterine conditions.
Official title: To authorize the Secretary of Health and Human Services to award grants to increase early detection of and intervention for uterine fibroids, and for other purposes.
Introduced July 15, 2025 by Shontel M. Brown · Last progress July 15, 2025
This bill directs federal funding, research, screening, and reporting to detect and treat uterine fibroids earlier and reduce disparities—improving care for many women—but increases federal and local costs, risks uneven implementation, and leaves key funding and oversight details unspecified, which could delay or limit benefits.
Women at risk for or living with uterine fibroids will get earlier detection and referral to care through evidence-based strategies, funded screening, patient navigation, and public awareness campaigns, reducing symptoms and improving quality of life.
Women with uterine fibroids will likely see better treatment options and pain management as targeted research grants and clinical trials generate improved surgical practices and therapies.
Racial, ethnic, and low-income populations in high-risk communities will receive prioritized resources (screening, navigation, and disparity-focused research), helping reduce reproductive health inequities.
Taxpayers and the federal budget will face higher costs because of new grant programs, research funding, and implementation expenses, which could divert funds from other priorities.
Access and benefits may be uneven across states and communities—implementation variations and local provider capacity mean some women (especially in certain states or rural areas) may not benefit immediately.
The bill does not specify funding amounts, timelines, or eligibility for grants and research, creating a risk that programs will be delayed, underfunded, or slow to deliver benefits to patients.
Based on analysis of 5 sections of legislative text.
Authorizes HHS to research and develop evidence-based strategies to improve early detection and intervention for uterine fibroids, and to award grants to states for screening, patient navigation, awareness campaigns, and access improvements. Directs HHS to fund research (including clinical trials) on disparities in pain management for fibroid surgery and intrauterine conditions such as Asherman’s Syndrome, and requires biennial public reporting to Congress and posting on HHS’s website. Targets grant priority to programs serving socially vulnerable populations at elevated risk and requires that the Secretary finalize detection strategies quickly so states can implement them. The Act sets program goals, research topics, allowable grant uses, and reporting deadlines but does not specify funding amounts, eligibility details, or deadlines for awards.